The theme of this third edition, “Enhancing Predictivity in Medicines Development” will focus on bringing together the latest technologies to increase success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodology for patient selection and stratification.

For this year’s edition, you will hear from – among others – Mark Schmidt (Senior Director, Janssen Research and Development), Philip Murphy (Head, Experimental Medicine Imaging, GSK), Christopher Austin (NIH-NCATS, United States).

The programme also includes a pre-conference day on Sunday, September 24, dedicated to a series of educational workshops tackling topics in the field such as molecular imaging, biomarker validation or potency assays for ATMP’s and vaccines.

Translational Medicine 2017 also welcomes abstract submissions in the two following categories until May 15, 2017:

  1. Novel approaches in clinical development
  2. Developing more predictive preclinical tools to better reach proof of concept


Other information

Event host: European Infrastructure for Translational Medicine
Event venue: Corinthia Hotel, Kongresova 1, Prague
Connect on social media:

For more information, please visit:

Questions? Send an email to: